Perimenopause Hair Loss: Causes & How to Restore Growth

Perimenopause Symptoms: –

Hot flashes & night sweats Most hallmark symptoms.

Caused by falling oestrogen, disrupting the brain’s temperature control centre.

Irregular periods First sign.

Cycles become unpredictable – shorter, longer, heavier, or skipped. Lasts 5-10 years on average.

Brain fog & mood changes Up to 70% of women experience anxiety, low mood, or poor concentration. Oestrogen receptors exist throughout the brain.
Sleep disruption Night sweats, insomnia, and restless legs – often triggered by declining oestrogen and progesterone levels.
Vaginal dryness Declining oestrogen thins vaginal tissue – causes dryness, discomfort, and urinary changes.
Weight & joint changes Metabolism slows; fat redistributes to the abdomen. Muscle and joint pain are commonly reported during perimenopause, although prevalence and severity may vary among populations.

Hormone tests – when they matter and why they are measured: –

Test What It Shows When It’s Useful Limitation
FSH

(key marker)

A pituitary hormone that rises as ovarian function declines Women under 40 with suspected early menopause (POI); after hysterectomy Fluctuates daily in perimenopause – one result means little
Oestradiol (E2)

(key marker)

Main oestrogen; low E2 drives hot flashes, dryness, mood changes Confirming hormonal decline; guiding HRT dosing Levels swing unpredictably – best read alongside symptoms
AMH

(ovarian reserve)

Reflects how many follicles remain; declines to zero at menopause Predicting the timing of menopause; early menopause risk assessment Not yet standard in routine menopause diagnosis
LH

(supporting)

Rises irregularly in perimenopause; chronically elevated at menopause Alongside FSH to rule out other hormonal conditions Surges unpredictably – not a standalone diagnostic marker
Progesterone

(supporting)

Drops as ovulation becomes irregular; linked to sleep and mood Assessing cycle regularity; sleep and mood symptom guidance Only meaningful if tested at the correct cycle day – unreliable in irregular cycles
Testosterone

(Optional)

Affects libido, energy, and mood; rises slightly post-menopause If low libido or fatigue is a dominant concern Not routinely tested; interpretation standards still evolving

 The main highlight of the medical guidelines is that women over the age of 45 generally do not require hormone testing to diagnose perimenopause or menopause; rather, these women should be diagnosed on the basis of their symptoms. Hormone levels fluctuate considerably during perimenopause, meaning that a single test result may not accurately reflect hormonal status. Hormonal testing is generally reserved for women under 40 years of age, women who have undergone a hysterectomy, or those in whom another medical condition must be excluded. 

We can see 3 types of hair loss in perimenopause

1) Diffuse thinning (female pattern hair loss): – This is most commonly found characterised by a reduction in hair volume across the scalp. Triggered by falling oestrogen and rising androgen activity, hair follicles miniaturize gradually.

Signs: ponytail feels thinner, wider parting, more scalp visible in sunlight.

2) Female pattern hair loss (Androgenetic alopecia): -In this, we see pattern loss where the hairline recedes at the temples; the crown thins, but the frontal hairline usually stays intact. Driven by DHT sensitivity in follicles.

Signs: M-shaped recession at temples, visible scalp at crown, hair becomes finer and less dense.

3) Telogen effluvium (TE): – This shedding type of hair loss causes sudden mass shedding triggered by hormonal shock, stress, crash dieting, or illness. Hair enters the resting phase early and sheds in clumps 2-3 months later.

Signs: handfuls in the shower, pillow hair, sudden onset; often resolves on its own.

Diffuse thinning (female pattern hair loss) and androgenetic alopecia are chronic and progressive which require ongoing treatment. Telogen effluvium is usually temporary and resolves within 6-9 months once the trigger is removed.

 Treatment comparison table

Treatment Evidence Timeline Best For Watch Out
Topical Minoxidil 5% 88% maintain hair at 48 weeks 3-6 months to see results; ongoing use required FPHL, androgenetic alopecia – all types benefit Initial shedding (weeks 1-8); scalp irritation; must not stop suddenly
Oral Minoxidil (0.25-1mg) Comparable to topical; fewer scalp side effects 3-6 months; ongoing use Women who dislike topical formulas or have scalp sensitivity Facial hair growth, fluid retention – requires a prescription from a GP
HRT (Oestrogen + Progesterone) Indirect benefit: supports the follicle environment 6-12 months; hair benefit secondary to hormonal balance Women with multiple perimenopause symptoms – hair benefit is a bonus Not prescribed solely for hair loss; individual risk assessment needed
Spironolactone (anti-androgen) 43 % improvement alone; 66% with minoxidil 6-12 months Androgenetic / pattern loss with androgen excess; PCOS-related loss Not safe in pregnancy; can lower blood pressure; needs regular monitoring
PRP (Platelet-Rich Plasma) Emerging, promising for density, not regrowth 3-6 sessions; results Early-stage FPHL; when topicals are not tolerated Expensive; not NHS-funded; semi-experimental
Supplements (Biotin, Fe, Vit D, Zinc) Only effective if the deficiency is confirmed 3-6 months TE caused by nutritional deficiency; adjunct to main treatment No supplement is FDA-approved for hair loss; biotin alone rarely works
Rosemary Oil (Topical) Comparable to minoxidil 2% in a 2015 RCT 6 months of consistent use Mild diffuse thinning; those preferring natural options Less evidence than minoxidil 5%; best as an adjunct

 Specialist Guide

  • How to use minoxidil

Apply 1 ml to the dry scalp twice a day (or foam once a day) at the parting line and crown. Avoid washing for 4 hours. Initial shedding (week 2-8) is normal. Continuous use is necessary.

Products: Regaine® Women 5% Foam, Kirkland 5% solution, Hims/hers topical

  • HRT – hair-specific notes

Oestradiol patches/gel preferred, micronised progesterone recommended. Avoid norethisterone. Hair changes visible in 6-12 months.

Products: Oestrogel, Evorel patches, Utrogestan capsules.

  • Do Supplements actually work

Check ferritin, Vit D, zinc, and B12 before supplementation. Ferritin < 70 mcg/L increases shedding – supplement if low. Vit D 1,500-2,000 IU daily if deficient. Biotin is needed only if deficient.

Products: Florisene, Nutrafol, Viviscal.

  • PRP – what to expect

Blood is drawn and centrifuged to concentrate platelets, then injected into the scalp over 3-4 sessions. Reduces shedding and improves density. Combine with minoxidil; maintenance every 6-12 months.

When to see a dermatologist vs GP

See your GP first if

  • Signs of hair loss started with other symptoms of perimenopause.
  • You want to have certain blood tests done to check your vitamin D, ferritin, thyroid levels, and B12 levels.
  • You are currently considering hormone replacement therapy (HRT) to manage more than just hair loss.
  • Your hair loss is gradual and mild with uniform thinning of the hair.
  • You would like a referral or Rx for minoxidil and/or spironolactone.
  • You have experienced sudden thick hair loss after an incident of stress, illness or a crash diet.

See a Dermatologist if

  • Possible autoimmune alopecia areata with scalp itchiness, scaling, redness, and hair loss.
  • Minoxidil or general practitioner treatment is ineffective after six months.
  • Significant temple recession and/or crown thinning (androgenetic alopecia/pattern hair loss).
  • Consider PRP (platelet-rich plasma) or microneedling and low-level laser therapy.
  • Eyebrow/eyelash loss is happening along with hair loss from the scalp.

Where is the cheapest place to get a hormone test in Singapore?

The cheapest options are ATA Medical and HealthScreening.sg. You can access all types of hormonal testing for as little as $32.70 NETT (including GST), with each test available for same-day appointments at multiple MRT-accessible locations. Among many options for a complete perimenopausal panel, Love & Joy Family Clinic in Clementi offers the best price for a full menopause evaluation, including E2, FSH, LH, progesterone, and prolactin, for only $120. You may also have the AMH test done for an additional $80.50. Regis Medical in Holland Village/Katong offers testosterone ($35), TSH ($45), or a complete 8-marker full female hormonal panel ($220) with results provided within 3 business days. Zora Health specialises exclusively in menopause- and hormonal health-related diagnostics, with expert-directed result interpretation. Pricing is available by contacting Zora Health directly. 

Overall, if you’re looking for the lowest cost, start your search with ATA Medical or HealthScreening.sg for single tests. For the best-priced complete menopause panel, you can’t beat Love & Joy at $120. When factoring total test costs, remember to allow an additional $38-$49 for the consultation.

Frequently Asked Questions

Will my hair grow back after menopause?

For many women, yes. The timeline and extent of regrowth depend on the type of hair loss and how early it is addressed. Once hormone levels stabilise after menopause, some women notice a natural reduction in hair shedding, while treatments such as nutritional supplementation, topical therapies, and hormone management may further support hair recovery. Research suggests that oestrogen-only hormone replacement therapy (HRT) may improve hair density and strand strength within six months for some women, although individual responses vary. Early intervention, before significant follicle miniaturisation occurs, offers the best chance of meaningful regrowth.

Why is my hair thinning during perimenopause?

Hair thinning during perimenopause is primarily driven by declining levels of oestrogen and progesterone. As these hormones decrease, androgens become relatively more dominant, which can shrink hair follicles and shorten the hair growth cycle. Lower progesterone levels may also reduce the body’s natural protection against dihydrotestosterone (DHT), a hormone associated with follicle miniaturisation. Studies estimate that approximately 40–50% of women experience noticeable hair thinning during perimenopause. While common, hair loss during this stage can often be stabilised and managed with appropriate evaluation and treatment.

Should I get my hormones tested if my hair is falling out?

Hormone testing can be helpful when investigating hair loss, but it should not be the only aspect of assessment. Nutritional deficiencies and thyroid disorders are also common contributors to hair thinning and shedding. Depending on your symptoms, your doctor may recommend testing oestrogen, testosterone, DHEA, thyroid-stimulating hormone (TSH), ferritin, vitamin D, and other relevant markers. The results should always be interpreted alongside your medical history, symptoms, and pattern of hair loss to identify the underlying cause and guide treatment decisions.

Does HRT help with perimenopause hair loss?

Hormone replacement therapy (HRT) may help some women experiencing hair loss related to declining oestrogen levels, but it is not specifically prescribed as a hair loss treatment and results vary between individuals. By restoring oestrogen levels, HRT may improve hair density and reduce androgen-related thinning in some women. However, if hair loss is caused by factors other than hormonal changes, HRT may have limited benefit. Women using HRT that contains testosterone should be aware that testosterone may worsen hair loss in those genetically predisposed to androgenetic alopecia. Research has shown that some women experience improvements in hair density and strand strength after several months of oestrogen-based HRT.

Is perimenopause hair loss permanent?

Not necessarily. Many women can stabilise hair shedding and achieve some degree of regrowth when the underlying cause is identified and treated early. The duration of follicle miniaturisation plays an important role in treatment success. Hair follicles that have only recently begun to shrink are generally more responsive to treatment than follicles that have been inactive for many years. In most cases, reducing hair shedding is the first sign that treatment is working, while visible regrowth may take several months. Consistent treatment and ongoing management are often necessary to achieve the best possible outcomes.

References: 

  1. Almohanna, H. M., Ahmed, A. A., Tsatalis, J. P., & Tosti, A. (2018). The Role of Vitamins and Minerals in Hair Loss: A Review. Dermatology and Therapy, 9(1), 51–70. https://doi.org/10.1007/s13555-018-0278-6 
  2. Burns, L. J., De Souza, B., Flynn, E., Hagigeorges, D., & Senna, M. M. (2020). Spironolactone for treatment of female pattern hair loss. Journal of the American Academy of Dermatology, 83(1), 276–278. https://doi.org/10.1016/j.jaad.2020.03.087 
  3. Gupta, A. K., Economopoulos, V., Mann, A., Wang, T., & Mirmirani, P. (2025). Menopause and hair loss in women: Exploring the hormonal transition. Maturitas, 198, 108378. https://doi.org/10.1016/j.maturitas.2025.108378 
  4. Kamp, E., Ashraf, M., Musbahi, E., & DeGiovanni, C. (2022). Menopause, skin and common dermatoses. Part 1: Hair disorders. Clinical and Experimental Dermatology, 47(12), 2110–2116. https://doi.org/10.1111/ced.15327 
  5. Lucky, A. W., Piacquadio, D. J., Ditre, C. M., Dunlap, F., Kantor, I., Pandya, A. G., Savin, R. C., & Tharp, M. D. (2004). A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Journal of the American Academy of Dermatology, 50(4), 541–553. https://doi.org/10.1016/j.jaad.2003.06.014 
  6. Lumsden, M. A., & Hardman, S. (2025). NICE guidelines on menopause are missing nuance. BMJ, 389, r1077. https://doi.org/10.1136/bmj.r1077 
  7. Malkud, S. (2015). Telogen Effluvium: A Review. Journal of Clinical and Diagnostic Research: JCDR, 9(9), WE01-03. https://doi.org/10.7860/JCDR/2015/15219.6492 
  8. Müller Ramos, P., Melo, D. F., Radwanski, H., de Almeida, R. F. C., & Miot, H. A. (2023). Female-pattern hair loss: Therapeutic update. Anais Brasileiros de Dermatologia, 98(4), 506–519. https://doi.org/10.1016/j.abd.2022.09.006 
  9. New Collective Author. (2023). The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause, 30(6), 573–590. https://doi.org/10.1097/GME.0000000000002200 
  10. Panahi, Y., Taghizadeh, M., Marzony, E. T., & Sahebkar, A. (2015). Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: A randomized comparative trial. Skinmed, 13(1), 15–21. 
  11. Vañó-Galván, S., Pirmez, R., Hermosa-Gelbard, A., Moreno-Arrones, Ó. M., Saceda-Corralo, D., Rodrigues-Barata, R., Jimenez-Cauhe, J., Koh, W. L., Poa, J. E., Jerjen, R., Trindade de Carvalho, L., John, J. M., Salas-Callo, C. I., Vincenzi, C., Yin, L., Lo-Sicco, K., Waskiel-Burnat, A., Starace, M., Zamorano, J. L., … Bhoyrul, B. (2021). Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. Journal of the American Academy of Dermatology, 84(6), 1644–1651. https://doi.org/10.1016/j.jaad.2021.02.054 
  12. Varothai, S., & Bergfeld, W. F. (2014). Androgenetic alopecia: An evidence-based treatment update. American Journal of Clinical Dermatology, 15(3), 217–230. https://doi.org/10.1007/s40257-014-0077-5 

Latest articles

Most Read Articles
zora-logo
Explore the
Zora Health App

No more endless research — save time, reduce stress, and get the answers you need, all in one place.